{"resourceType":"Bundle","id":"tests-5ecfd8be-9059-4824-bb5b-a6fda589a366-bundle","type":"transaction","entry":[{"fullUrl":"https://madie.cms.gov/Patient/5ecfd8be-9059-4824-bb5b-a6fda589a366","resource":{"resourceType":"Patient","id":"5ecfd8be-9059-4824-bb5b-a6fda589a366","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-patient"]},"extension":[{"url":"http://hl7.org/fhir/us/core/StructureDefinition/us-core-race","extension":[{"url":"ombCategory","valueCoding":{"system":"urn:oid:2.16.840.1.113883.6.238","code":"2054-5","display":"Black or African American","userSelected":true}},{"url":"text","valueString":"Black or African American"}]},{"url":"http://hl7.org/fhir/us/core/StructureDefinition/us-core-ethnicity","extension":[{"url":"ombCategory","valueCoding":{"system":"urn:oid:2.16.840.1.113883.6.238","code":"2135-2","display":"Hispanic or Latino","userSelected":true}},{"url":"text","valueString":"Hispanic or Latino"}]}],"identifier":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/v2-0203","code":"MR"}]},"system":"https://bonnie-fhir.healthit.gov/","value":"62fd0c5185b0356a7c28532e"}],"name":[{"family":"DenomFail","given":["FirstTXEndsAfterMP"]}],"gender":"unknown","birthDate":"2000-01-01"},"request":{"method":"PUT","url":"Patient/5ecfd8be-9059-4824-bb5b-a6fda589a366"}},{"fullUrl":"https://madie.cms.gov/Condition/prostate-cancer-a8d8","resource":{"resourceType":"Condition","id":"fd1bf961-fef6-433c-8a41-b452d03a0dca","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-condition"]},"clinicalStatus":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/condition-clinical","code":"active","display":"active","userSelected":true}]},"category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/condition-category","code":"problem-list-item","display":"Problem List Item"},{"system":"http://snomed.info/sct","code":"439401001","display":"Diagnosis"}]}],"code":{"coding":[{"system":"http://snomed.info/sct","version":"2022-03","code":"254900004","display":"Carcinoma of prostate (disorder)","userSelected":true}]},"subject":{"reference":"Patient/5ecfd8be-9059-4824-bb5b-a6fda589a366"},"onsetPeriod":{"start":"2010-06-14T08:00:00.000+00:00"}},"request":{"method":"PUT","url":"Condition/fd1bf961-fef6-433c-8a41-b452d03a0dca"}},{"fullUrl":"https://madie.cms.gov/Procedure/prostate-cancer-treatment-a8d9","resource":{"resourceType":"Procedure","id":"325469c8-3382-46a8-ae11-b22e88147a6c","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-procedure"]},"extension":[{"url":"http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-recorded","valueDateTime":"2025-02-01T09:00:00.000+00:00"}],"status":"completed","code":{"coding":[{"system":"http://snomed.info/sct","version":"2022-03","code":"10492003","display":"Radionuclide therapy for glandular suppression (procedure)","userSelected":true}]},"subject":{"reference":"Patient/5ecfd8be-9059-4824-bb5b-a6fda589a366"},"performedDateTime":"2025-01-01T08:00:00.000+00:00"},"request":{"method":"PUT","url":"Procedure/325469c8-3382-46a8-ae11-b22e88147a6c"}},{"fullUrl":"https://madie.cms.gov/Observation/prostate-specific-antigen-test-a8da","resource":{"resourceType":"Observation","id":"22f9b4f7-a999-4243-baef-52db8e2eaeef","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-observation"]},"status":"final","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/observation-category","code":"procedure","display":"Procedure"}]}],"code":{"coding":[{"system":"http://loinc.org","version":"2.72","code":"10508-0","display":"Prostate specific Ag [Presence] in Tissue by Immune stain","userSelected":true}]},"subject":{"reference":"Patient/5ecfd8be-9059-4824-bb5b-a6fda589a366"},"issued":"2025-04-22T08:00:00.000+00:00","valueQuantity":{"value":11.0,"system":"http://unitsofmeasure.org","code":"ng/mL"}},"request":{"method":"PUT","url":"Observation/22f9b4f7-a999-4243-baef-52db8e2eaeef"}},{"fullUrl":"https://madie.cms.gov/Observation/gleason-score-in-specimen-qualitative-a8dc","resource":{"resourceType":"Observation","id":"bae28fce-014f-4d07-8d63-a96a0affa834","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-observation"]},"status":"final","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/observation-category","code":"procedure","display":"Procedure"}]}],"code":{"coding":[{"system":"http://loinc.org","code":"35266-6","display":"Gleason score in Specimen Qualitative","userSelected":true}]},"subject":{"reference":"Patient/5ecfd8be-9059-4824-bb5b-a6fda589a366"},"effectiveDateTime":"2025-01-02T08:00:00.000+00:00","valueInteger":5},"request":{"method":"PUT","url":"Observation/bae28fce-014f-4d07-8d63-a96a0affa834"}},{"fullUrl":"https://madie.cms.gov/Observation/tumor-staging-tumor-staging-a8dd","resource":{"resourceType":"Observation","id":"de47080e-afee-4806-80c3-c1d685b9d779","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-observation"]},"status":"final","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/observation-category","code":"procedure","display":"Procedure"}]}],"code":{"coding":[{"system":"http://snomed.info/sct","code":"254292007","display":"Tumor staging (tumor staging)","userSelected":true}]},"subject":{"reference":"Patient/5ecfd8be-9059-4824-bb5b-a6fda589a366"},"effectiveDateTime":"2025-04-26T08:00:00.000+00:00","valueCodeableConcept":{"coding":[{"system":"http://snomed.info/sct","code":"433361000124104","display":"Neoplasm of prostate primary tumor staging category T2a: Involves one-half of one lobe or less (finding)","userSelected":true}]}},"request":{"method":"PUT","url":"Observation/de47080e-afee-4806-80c3-c1d685b9d779"}},{"fullUrl":"https://madie.cms.gov/Coverage/1","resource":{"resourceType":"Coverage","id":"79e20b20-5cf8-4895-8020-60317cb21a91","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-coverage"]},"status":"active","beneficiary":{"reference":"Patient/5ecfd8be-9059-4824-bb5b-a6fda589a366"},"payor":[{"reference":"Organization/80573fa1-cf83-4e9a-8f21-86a018689678"}]},"request":{"method":"PUT","url":"Coverage/79e20b20-5cf8-4895-8020-60317cb21a91"}},{"fullUrl":"https://madie.cms.gov/Organization/123456","resource":{"resourceType":"Organization","id":"80573fa1-cf83-4e9a-8f21-86a018689678","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-organization"]},"identifier":[{"use":"temp","system":"urn:oid:2.16.840.1.113883.4.4","value":"21-3259825"}],"active":true,"type":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/organization-type","code":"pay","display":"Payer"}]}],"name":"Blue Cross Blue Shield of Texas","telecom":[{"system":"phone","value":"(+1) 972-766-6900"}],"address":[{"use":"billing","type":"postal","line":["P.O. Box 660044"],"city":"Dallas","state":"TX","postalCode":"75266-0044","country":"USA"}]},"request":{"method":"PUT","url":"Organization/80573fa1-cf83-4e9a-8f21-86a018689678"}},{"fullUrl":"https://madie.cms.gov/Practitioner/practitioner-123456","resource":{"resourceType":"Practitioner","id":"e3ddfa2a-23b3-4060-a508-175e1ffc9b9d","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-practitioner"]},"identifier":[{"system":"http://hl7.org/fhir/sid/us-npi","value":"123456"}],"name":[{"family":"Evil","prefix":["Dr"]}]},"request":{"method":"PUT","url":"Practitioner/e3ddfa2a-23b3-4060-a508-175e1ffc9b9d"}},{"fullUrl":"https://madie.cms.gov/MeasureReport/78171bc8-1449-4cf1-b0ea-afbd2adda3de","resource":{"resourceType":"MeasureReport","id":"78171bc8-1449-4cf1-b0ea-afbd2adda3de","meta":{"profile":["http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/test-case-cqfm"]},"contained":[{"resourceType":"Parameters","id":"e6a00e19-2a03-4700-b2a0-f1c06f6d6dae-parameters","parameter":[{"name":"subject","valueString":"5ecfd8be-9059-4824-bb5b-a6fda589a366"}]}],"extension":[{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-inputParameters","valueReference":{"reference":"#e6a00e19-2a03-4700-b2a0-f1c06f6d6dae-parameters"}},{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-testCaseDescription","valueMarkdown":"Prostate Ca Diagnosis but does not meet first treatment. Meets tumor staging, PSA, and Gleason.  First treatment ends after MP. "}],"modifierExtension":[{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-isTestCase","valueBoolean":true}],"status":"complete","type":"individual","measure":"https://madie.cms.gov/Measure/ProstateCaAvoidanceBoneScanOveruseFHIR","period":{"start":"2025-01-01","end":"2025-12-31"},"group":[{"population":[{"code":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/measure-population","code":"initial-population","display":"Initial Population"}]},"count":1},{"code":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/measure-population","code":"denominator","display":"Denominator"}]},"count":0},{"code":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/measure-population","code":"numerator","display":"Numerator"}]},"count":0},{"code":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/measure-population","code":"denominator-exception","display":"Denominator Exception"}]},"count":0}]}]},"request":{"method":"PUT","url":"MeasureReport/78171bc8-1449-4cf1-b0ea-afbd2adda3de"}}]}